What is Phathom Pharmaceuticals, Inc. Common Stock's Market Cap?

Phathom Pharmaceuticals, Inc. Common Stock's Market Cap is $762.9M, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Phathom Pharmaceuticals, Inc. Common Stock's Enterprise Value is $745.0M, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's Price / Sales?

Phathom Pharmaceuticals, Inc. Common Stock's Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's EV / Revenue?

Phathom Pharmaceuticals, Inc. Common Stock's EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Phathom Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Phathom Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $239.7M, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Phathom Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$99.1M, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's EBITDA?

Phathom Pharmaceuticals, Inc. Common Stock's EBITDA is -$40.1M, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Phathom Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.22, based on as-reported figures from SEC (XBRL) filings.

What is Phathom Pharmaceuticals, Inc. Common Stock's EBITDA Margin?

Phathom Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -16.7%, based on as-reported figures from SEC (XBRL) filings.

Phathom Pharmaceuticals, Inc. Common Stock (PHAT) Financial Statements

Phathom Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00P5B2S73

XNAS · usd

9.43▼ 0.07 (-0.74%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close9.50

Day's Range9.22 – 9.65

52-Week Range8.21 – 18.31

Volume1.0M

Avg Volume1.5M

Share Statistics

Shares Outstanding

Employees371

ExchangeXNAS

Listed2019-10-25

Share count as of July 27, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Phathom Pharmaceuticals, Inc. Common Stock (PHAT)

What is Phathom Pharmaceuticals, Inc. Common Stock's Market Cap?: Phathom Pharmaceuticals, Inc. Common Stock's Market Cap is $762.9M, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Phathom Pharmaceuticals, Inc. Common Stock's Enterprise Value is $745.0M, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's Price / Sales?: Phathom Pharmaceuticals, Inc. Common Stock's Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's EV / Revenue?: Phathom Pharmaceuticals, Inc. Common Stock's EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Phathom Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Phathom Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $239.7M, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Phathom Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$99.1M, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's EBITDA?: Phathom Pharmaceuticals, Inc. Common Stock's EBITDA is -$40.1M, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Phathom Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.22, based on as-reported figures from SEC (XBRL) filings.
What is Phathom Pharmaceuticals, Inc. Common Stock's EBITDA Margin?: Phathom Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -16.7%, based on as-reported figures from SEC (XBRL) filings.